(CB) Chubb - Overview
Exchange: NYSE •
Country: Switzerland •
Currency: USD •
Type: Common Stock •
ISIN: CH0044328745
Stock: Property, Casualty, Reinsurance, Life, Agriculture
Total Rating 58
Risk 74
Buy Signal 0.03
| Risk 5d forecast | |
|---|---|
| Volatility | 18.6% |
| Relative Tail Risk | -6.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.41 |
| Alpha | 5.72 |
| Character TTM | |
|---|---|
| Beta | 0.072 |
| Beta Downside | 0.356 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.35% |
| CAGR/Max DD | 1.55 |
EPS (Earnings per Share)
Revenue
Description: CB Chubb March 05, 2026
Chubb Limited (CB) is a global insurer and reinsurer, offering a broad range of products across six segments. The company provides both commercial and personal property & casualty (P&C) insurance, a core offering in the insurance sector.
Its commercial lines include package policies, workers compensation, and professional liability. Personal lines cover homeowners, automobile, and high-value articles. Agricultural insurance is also a significant offering, providing specialized coverage for crops and farms.
Chubbs overseas general insurance and global reinsurance segments extend its reach internationally. Reinsurance is a critical component of the insurance business model, allowing insurers to transfer risk. The company also underwrites life insurance and related protection and savings products.
For a deeper dive into Chubbs financial performance and market position, consider exploring its detailed analytics on ValueRay.
Headlines to watch out for
- Commercial P&C premium growth drives revenue
- Catastrophe losses impact underwriting profitability
- Interest rate changes affect investment income
- Global economic conditions influence insurance demand
- Regulatory changes alter compliance costs and market access
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 10.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.11 > 1.0 |
| NWC/Revenue: 28.31% < 20% (prev 24.28%; Δ 4.03% < -1%) |
| CFO/TA 0.05 > 3% & CFO 13.52b > Net Income 10.31b |
| Net Debt (19.72b) to EBITDA (14.13b): 1.40 < 3 |
| Current Ratio: 12.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (396.5m) vs 12m ago -7.30% < -2% |
| Gross Margin: 33.42% > 18% (prev 0.29%; Δ 3.31k% > 0.5%) |
| Asset Turnover: 24.17% > 50% (prev 22.76%; Δ 1.41% > 0%) |
| Interest Coverage Ratio: 18.01 > 6 (EBITDA TTM 14.13b / Interest Expense TTM 764.0m) |
Altman Z'' 2.15
| A: 0.07 (Total Current Assets 18.41b - Total Current Liabilities 1.50b) / Total Assets 247.83b |
| B: 0.28 (Retained Earnings 69.95b / Total Assets 247.83b) |
| C: 0.06 (EBIT TTM 13.76b / Avg Total Assets 247.19b) |
| D: 0.39 (Book Value of Equity 65.21b / Total Liabilities 168.05b) |
| Altman-Z'' Score: 2.15 = BBB |
Beneish M -3.60
| DSRI: 0.43 (Receivables 15.94b/34.49b, Revenue 59.75b/56.12b) |
| GMI: 0.86 (GM 33.42% / 28.76%) |
| AQI: 0.98 (AQ_t 0.91 / AQ_t-1 0.93) |
| SGI: 1.06 (Revenue 59.75b / 56.12b) |
| TATA: -0.01 (NI 10.31b - CFO 13.52b) / TA 247.83b) |
| Beneish M-Score: -3.60 (Cap -4..+1) = AAA |
What is the price of CB shares?
As of March 20, 2026, the stock is trading at USD 323.64 with a total of 2,196,981 shares traded.
Over the past week, the price has changed by -1.51%, over one month by -1.39%, over three months by +4.51% and over the past year by +10.67%.
Over the past week, the price has changed by -1.51%, over one month by -1.39%, over three months by +4.51% and over the past year by +10.67%.
Is CB a buy, sell or hold?
Chubb has received a consensus analysts rating of 3.45.
Therefor, it is recommend to hold CB.
- StrongBuy: 4
- Buy: 5
- Hold: 10
- Sell: 3
- StrongSell: 0
What are the forecasts/targets for the CB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 337.7 | 4.3% |
| Analysts Target Price | 337.7 | 4.3% |
CB Fundamental Data Overview March 16, 2026
P/E Trailing = 12.8054
P/E Forward = 12.2249
P/S = 2.1713
P/B = 1.7402
P/EG = 2.9105
Revenue TTM = 59.75b USD
EBIT TTM = 13.76b USD
EBITDA TTM = 14.13b USD
Long Term Debt = 15.73b USD (from longTermDebt, last quarter)
Short Term Debt = 5.03b USD (from shortTermDebt, last quarter)
Debt = 22.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.72b USD (from netDebt column, last quarter)
Enterprise Value = 149.18b USD (129.47b + Debt 22.19b - CCE 2.47b)
Interest Coverage Ratio = 18.01 (Ebit TTM 13.76b / Interest Expense TTM 764.0m)
EV/FCF = 11.04x (Enterprise Value 149.18b / FCF TTM 13.52b)
FCF Yield = 9.06% (FCF TTM 13.52b / Enterprise Value 149.18b)
FCF Margin = 22.62% (FCF TTM 13.52b / Revenue TTM 59.75b)
Net Margin = 17.26% (Net Income TTM 10.31b / Revenue TTM 59.75b)
Gross Margin = 33.42% ((Revenue TTM 59.75b - Cost of Revenue TTM 39.78b) / Revenue TTM)
Gross Margin QoQ = 49.20% (prev 31.18%)
Tobins Q-Ratio = 0.60 (Enterprise Value 149.18b / Total Assets 247.83b)
Interest Expense / Debt = 0.92% (Interest Expense 205.0m / Debt 22.19b)
Taxrate = 15.84% (597.0m / 3.77b)
NOPAT = 11.58b (EBIT 13.76b * (1 - 15.84%))
Current Ratio = 12.28 (Total Current Assets 18.41b / Total Current Liabilities 1.50b)
Debt / Equity = 0.30 (Debt 22.19b / totalStockholderEquity, last quarter 73.76b)
Debt / EBITDA = 1.40 (Net Debt 19.72b / EBITDA 14.13b)
Debt / FCF = 1.46 (Net Debt 19.72b / FCF TTM 13.52b)
Total Stockholder Equity = 70.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.17% (Net Income 10.31b / Total Assets 247.83b)
RoE = 14.69% (Net Income TTM 10.31b / Total Stockholder Equity 70.18b)
RoCE = 16.01% (EBIT 13.76b / Capital Employed (Equity 70.18b + L.T.Debt 15.73b))
RoIC = 13.44% (NOPAT 11.58b / Invested Capital 86.17b)
WACC = 5.39% (E(129.47b)/V(151.65b) * Re(6.18%) + D(22.19b)/V(151.65b) * Rd(0.92%) * (1-Tc(0.16)))
Discount Rate = 6.18% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.74%
[DCF] Terminal Value 86.96% ; FCFF base≈14.58b ; Y1≈15.57b ; Y5≈18.81b
[DCF] Fair Price = 1.38k (EV 556.98b - Net Debt 19.72b = Equity 537.26b / Shares 390.2m; r=5.90% [WACC]; 5y FCF grow 7.60% → 2.90% )
EPS Correlation: 75.02 | EPS CAGR: 19.80% | SUE: 1.88 | # QB: 6
Revenue Correlation: 91.01 | Revenue CAGR: 13.25% | SUE: 3.66 | # QB: 2
EPS next Quarter (2026-06-30): EPS=6.69 | Chg7d=-0.002 | Chg30d=+0.024 | Revisions Net=+7 | Analysts=21
EPS current Year (2026-12-31): EPS=26.77 | Chg7d=-0.064 | Chg30d=+0.068 | Revisions Net=+7 | Growth EPS=+8.0% | Growth Revenue=+5.1%
EPS next Year (2027-12-31): EPS=29.06 | Chg7d=+0.109 | Chg30d=+0.300 | Revisions Net=+2 | Growth EPS=+8.5% | Growth Revenue=+4.9%
[Analyst] Revisions Ratio: +0.78 (8 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.1% (Discount Rate 7.9% - Earnings Yield 7.8%)
[Growth] Growth Spread = +4.9% (Analyst 5.0% - Implied 0.1%)
P/E Forward = 12.2249
P/S = 2.1713
P/B = 1.7402
P/EG = 2.9105
Revenue TTM = 59.75b USD
EBIT TTM = 13.76b USD
EBITDA TTM = 14.13b USD
Long Term Debt = 15.73b USD (from longTermDebt, last quarter)
Short Term Debt = 5.03b USD (from shortTermDebt, last quarter)
Debt = 22.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.72b USD (from netDebt column, last quarter)
Enterprise Value = 149.18b USD (129.47b + Debt 22.19b - CCE 2.47b)
Interest Coverage Ratio = 18.01 (Ebit TTM 13.76b / Interest Expense TTM 764.0m)
EV/FCF = 11.04x (Enterprise Value 149.18b / FCF TTM 13.52b)
FCF Yield = 9.06% (FCF TTM 13.52b / Enterprise Value 149.18b)
FCF Margin = 22.62% (FCF TTM 13.52b / Revenue TTM 59.75b)
Net Margin = 17.26% (Net Income TTM 10.31b / Revenue TTM 59.75b)
Gross Margin = 33.42% ((Revenue TTM 59.75b - Cost of Revenue TTM 39.78b) / Revenue TTM)
Gross Margin QoQ = 49.20% (prev 31.18%)
Tobins Q-Ratio = 0.60 (Enterprise Value 149.18b / Total Assets 247.83b)
Interest Expense / Debt = 0.92% (Interest Expense 205.0m / Debt 22.19b)
Taxrate = 15.84% (597.0m / 3.77b)
NOPAT = 11.58b (EBIT 13.76b * (1 - 15.84%))
Current Ratio = 12.28 (Total Current Assets 18.41b / Total Current Liabilities 1.50b)
Debt / Equity = 0.30 (Debt 22.19b / totalStockholderEquity, last quarter 73.76b)
Debt / EBITDA = 1.40 (Net Debt 19.72b / EBITDA 14.13b)
Debt / FCF = 1.46 (Net Debt 19.72b / FCF TTM 13.52b)
Total Stockholder Equity = 70.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.17% (Net Income 10.31b / Total Assets 247.83b)
RoE = 14.69% (Net Income TTM 10.31b / Total Stockholder Equity 70.18b)
RoCE = 16.01% (EBIT 13.76b / Capital Employed (Equity 70.18b + L.T.Debt 15.73b))
RoIC = 13.44% (NOPAT 11.58b / Invested Capital 86.17b)
WACC = 5.39% (E(129.47b)/V(151.65b) * Re(6.18%) + D(22.19b)/V(151.65b) * Rd(0.92%) * (1-Tc(0.16)))
Discount Rate = 6.18% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.74%
[DCF] Terminal Value 86.96% ; FCFF base≈14.58b ; Y1≈15.57b ; Y5≈18.81b
[DCF] Fair Price = 1.38k (EV 556.98b - Net Debt 19.72b = Equity 537.26b / Shares 390.2m; r=5.90% [WACC]; 5y FCF grow 7.60% → 2.90% )
EPS Correlation: 75.02 | EPS CAGR: 19.80% | SUE: 1.88 | # QB: 6
Revenue Correlation: 91.01 | Revenue CAGR: 13.25% | SUE: 3.66 | # QB: 2
EPS next Quarter (2026-06-30): EPS=6.69 | Chg7d=-0.002 | Chg30d=+0.024 | Revisions Net=+7 | Analysts=21
EPS current Year (2026-12-31): EPS=26.77 | Chg7d=-0.064 | Chg30d=+0.068 | Revisions Net=+7 | Growth EPS=+8.0% | Growth Revenue=+5.1%
EPS next Year (2027-12-31): EPS=29.06 | Chg7d=+0.109 | Chg30d=+0.300 | Revisions Net=+2 | Growth EPS=+8.5% | Growth Revenue=+4.9%
[Analyst] Revisions Ratio: +0.78 (8 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.1% (Discount Rate 7.9% - Earnings Yield 7.8%)
[Growth] Growth Spread = +4.9% (Analyst 5.0% - Implied 0.1%)